A nonclinical study refers to research conducted on non-human subjects to gather data on the safety and efficacy of a drug, medical device, or treatment before it is tested in humans. These studies are typically performed in laboratory settings using cell cultures, tissues, or animal models to assess potential risks and benefits.
Nonclinical studies are a crucial step in the drug development process, providing valuable information on pharmacology, toxicology, and pharmacokinetics. They help researchers determine appropriate dosing, identify potential side effects, and establish a foundation for subsequent clinical trials involving human participants.
The term 'nonclinical study’ is crucial in clinical research as it represents a critical phase in drug development that precedes human trials. It provides essential safety and efficacy data that informs decisions on whether to proceed with clinical studies, helping to protect human subjects from unnecessary risks.
Understanding nonclinical studies is important for researchers, regulators, and sponsors involved in clinical trials. It aids in designing appropriate clinical protocols, interpreting results, and making informed decisions about drug candidates, ultimately contributing to the development of safer and more effective treatments.
We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…
The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…
The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…
Copyright @ 2025 Axcellant